Skip to content

PTHS PTHS Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number at other companies

Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
Exelixis logo
ExelixisEXEL
TTR
Turn Therapeutics Inc. Common StockTTRX

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number?
PTHS (PTHS) reported share-based compensation arrangement by share-based payment award, options, outstanding, number of $1.54M in Q1 2026.
How has PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number changed year-over-year?
PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number increased by 1668.4% year-over-year, from $87.05K to $1.54M.
What is the long-term trend for PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number?
Over 3 years (2022 to 2025), PTHS's share-based compensation arrangement by share-based payment award, options, outstanding, number has grown at a 211.2% compound annual growth rate (CAGR), from $50K to $1.51M.